Researchers Discover Key to Drug Resistance in Common Breast Cancer TreatmentTwo immune system molecules may be key to the development of drug resistance in estrogen-driven breast cancers.
Scientists Develop New Drug Delivery Method for Cancer TherapyA new design may make these drugs ideal vehicles for drug delivery straight to tumor cells.
Potential Drug Candidates Halt Prostate and Breast Cancer GrowthThe researchers say their new approach is like "designing a scalpel" to target only cancer cells.
In Battle for Real Estate, a Disordered Protein Wins OutThe new TSRI study points to a potential strategy to kill cancer cells.
New Enzyme-Like Tool Lets Chemists Modify Hard-to-Reach Spots on Drug MoleculesThe new tool works "like a crane and wrecking ball."
Fighting Blindness: TSRI Scientists Bring a Key Protein into FocusNew study could have implications for treating age-related macular degeneration and retinal dystrophy.
TSRI Announces New Board Members and Chairman of the BoardTSRI, one of the world's largest, private, non-profit research organizations, today announced the appointment of nine new members to its Board of Directors.
Researchers Find Standard Pacemakers and Defibrillators Safe for MRI Using a New ProtocolA closer look at the risk of MRI in 1,500 patients with implanted cardiac devices.
Ozanimod Shows Positive Results in Late-Stage Clinical Trial for Relapsing Multiple SclerosisThe new study demonstrated that a drug candidate originally discovered and optimized at TSRI can reduce the frequency of multiple sclerosis relapse.
Scripps Florida Scientists Take Aim at Obesity-Linked ProteinIs there a way to get metabolism to ramp up—even when it’s not cold out?
Researchers Awarded $3.3M to Develop Next-Generation Breast Cancer TherapiesThe team aims to help the thousands of patients whose current treatment options are limited.